Morgan Stanley Upgrades Azul to Equal-Weight, Raises Price Target to $8.6
Morgan Stanley analyst Josh Milberg upgrades Azul (NYSE:AZUL) from Underweight to Equal-Weight and raises the price target from $6 to $8.6.
Tesla, Amazon, Ambrx, BridgeBio, Azul: Why These 5 Stocks Are Drawing Investors’ Attention Today
U.S. markets closed mixed on Monday as investors and traders turned their attention toward Federal Reserve Chair Jerome…
Why Azul Stock Is Flying High Today
Azul S.A. (NYSE: AZUL) shares are trading higher on Monday after the company announced a deal to reduce the immediate cash it must expend for leased property.
Nasdaq Rises 50 Points; Ciena Earnings Top Expectations
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 50 points on Monday.
The Dow traded up 0.16% to 33,444.91 while the NASDAQ rose 0.43% to 11,739.11. The S&P 500 also rose, gaining, 0.35% to 4,059.80.
Dow Jumps Over 100 Points; BridgeBio Pharma Shares Spike Higher
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 100 points on Monday.
The Dow traded up 0.42% to 33,531.77 while the NASDAQ rose 0.97% to 11,802.73. The S&P 500 also rose, gaining, 0.69% to 4,073.40.
Kennedy-Wilson, Radian Group, BridgeBio Pharma And Other Big Stocks Moving Higher On Monday
U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Monday. Here are some big stocks recording gains in today’s session.
Earnings Scheduled For March 6, 2023
Companies Reporting Before The Bell
• Passage Bio (NASDAQ:PASG) is estimated to report earnings for its fourth quarter.
Top 5 Industrials Stocks That Could Lead To Your Biggest Gains In February
The most oversold stocks in the industrials sector presents an opportunity to buy into undervalued companies.
